0 Комментарии
0 Поделились
139 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
- Статьи пользователей
- Offers
- Jobs
- Войдите, чтобы отмечать, делиться и комментировать!
- Global (R)-(-)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid Industry Outlook, Chiral Intermediate Innovation, Pregabalin API Production & Neurology Drug Market Trends (2026-2034)Global (R)-(-)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid market was valued at USD 28.4 million in 2025 and is projected to reach USD 67.8 million by 2034, exhibiting a remarkable CAGR of 9.0% during the forecast period. (R)-(-)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid, a critical chiral intermediate and the pharmacologically active enantiomer essential for pregabalin synthesis, has...0 Комментарии 0 Поделились 669 Просмотры 0 предпросмотр
- Intermediate Caliber Ammunition (12.7mm, 14.5mm, 20mm) Market Growth Analysis, Dynamics, Key Players and Innovations, Outlook and Forecast 2026-2034According to a new report from Intel Market Research, the global Intermediate Caliber Ammunition (12.7mm, 14.5mm, 20mm) market was valued at USD 2.85 billion in 2025 and is projected to grow from USD 3.05 billion in 2026 to USD 5.12 billion by 2034, exhibiting a robust CAGR of 6.7% during the forecast period. This growth is propelled by rising global defense expenditures, ongoing military...0 Комментарии 0 Поделились 287 Просмотры 0 предпросмотр
- Primary Mediastinal Large B-cell Lymphoma Treatment Market Dynamics and Strategic Insights ReportAccording to the latest report published by Data Bridge Market Research, the Primary Mediastinal Large B-cell Lymphoma Treatment Market The global primary mediastinal large B-cell lymphoma treatment market size was valued at USD 850.00 million in 2025 and is expected to reach USD 1,354.77 million by 2033, at a CAGR of 6.00% during the forecast period The supreme Primary Mediastinal...0 Комментарии 0 Поделились 8 Просмотры 0 предпросмотр
- (R)-1-(2-Methoxyphenyl)-ethylamine Market 2026–2034: Growth in Chiral Pharmaceutical IntermediatesGlobal (R)-1-(2-Methoxyphenyl)-ethylamine (CAS 68285-23-4) market was valued at USD 28.4 million in 2025 and is projected to reach USD 52.7 million by 2034, exhibiting a remarkable CAGR of 7.3% during the forecast period. (R)-1-(2-Methoxyphenyl)-ethylamine is a chiral amine compound characterized by an ethylamine backbone bearing a 2-methoxyphenyl substituent in the (R)-enantiomeric...0 Комментарии 0 Поделились 370 Просмотры 0 предпросмотр
- (R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....0 Комментарии 0 Поделились 382 Просмотры 0 предпросмотр